Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q81961843)
Watch
English
REGARD: what can we learn from randomised, open-label, head-to-head studies?
scientific article published on 11 September 2008
In more languages
default values for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18789767
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18789767%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 January 2020
title
REGARD: what can we learn from randomised, open-label, head-to-head studies?
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18789767
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18789767%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 January 2020
author
Per Soelberg Sørensen
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18789767
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18789767%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 January 2020
publication date
11 September 2008
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18789767
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18789767%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 January 2020
published in
Lancet Neurology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18789767
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18789767%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 January 2020
volume
7
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18789767
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18789767%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 January 2020
issue
10
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18789767
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18789767%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 January 2020
page(s)
864-866
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18789767
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18789767%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 January 2020
cites work
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970201-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970201-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970201-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970201-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970201-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970201-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970201-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evidence of interferon beta-1a dose response in relapsing-remitting MS: the OWIMS Study. The Once Weekly Interferon for MS Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970201-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970201-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970201-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1474-4422(08)70201-1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18789767
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18789767%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 January 2020
PubMed publication ID
18789767
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18789767
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18789767%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit